603669.SS · 灵康药业
China A-shares · RS rating 97 · As of 2026-10-14
| Price | 7.33 CNY |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 98 / 88 / 86 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 52 / 54 / 47 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +97.5% |
| Distance from 52-week high | +9.6% |
| Market cap (USD) | $707.4M |